Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spect
AddedFeb 15, 2024
UpdatedJul 7, 2026
Spect

Spect

Seed

Spect: Data science leader in affordable retinal screening to prevent blindness.

HQ
Palo Alto, CA, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorS17
Overview
Compare
Fundraising
Employees
Website

Spect's core mission is to prevent blindness through value-based retinal screening in primary care settings. The company offers affordable and efficient retinal screening services, focusing on diseases like Diabetic Retinopathy and Glaucoma, which affect millions globally. By leveraging data science, Spect aims to streamline the diagnostic process, reducing the burden on ophthalmologists and eye clinics.

Spect has made significant strides in the field of vision disease prevention, impacting numerous diabetic patients worldwide. Their innovative approach has garnered attention for its potential to transform retinal screening protocols, making them more accessible and cost-effective.

Spect - Similar Companies

Quadrant Eye logo

Quadrant Eye

Intelligent Retinal Imaging Systems logo

Intelligent Retinal Imaging Systems

Vitazi.ai logo

Vitazi.ai

vitazi.ai

Retina Technologies logo

Retina Technologies

Insight Optics logo

Insight Optics

io.care

Retina-Ai Health logo

Retina-Ai Health

Eyenuk logo

Eyenuk

eyenuk.com

Eyebot logo

Eyebot

eyebot.tech

Optain logo

Optain

optainhealth.com

Scanbase logo

Scanbase

scanbase.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

SpecCheck logo

SpecCheck

speccheckrx.com

Perceptron Health logo

Perceptron Health

iHealthScreen logo

iHealthScreen

ihealthscreen.org

Altris.AI logo

Altris.AI

altris.ai

Spect - Quick Facts

Who are Spect's competitors?

Companies similar to Spect include Quadrant Eye, Intelligent Retinal Imaging Systems, Vitazi.ai and Retina Technologies.

When was Spect founded?

Spect was founded in 2017.

Where is Spect's headquarters located?

Spect's headquarters is located in Palo Alto, CA, US.

When was Spect's last funding round?

Spect's most recent funding round was for $3.5M (USD) in November 2021.

How much has Spect raised to-date?

As of Nov 30, 2021, Spect has raised a total of $5.1M (USD).

How many employees does Spect have?

Spect has 17 employees as of Feb 4, 2024.

Spect - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Retinal Screening
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software